Current partner codePEPTIDESDE
Evidence dashboardStudies since 2001Updated Jul 31, 2026

DesmopressinClinical Trials.

A source-linked view of every Desmopressin study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.

Total trials
75
Recruiting
8
Completed
39
Terminated
6
Results posted
7
Average enrollment
117
Countries
27
Highest phase
Phase 4

Developer / research origin

Multiple

Evidence summary

Activity is not efficacy.

Desmopressin appears in 75 indexed studies: 8 recruiting, 39 completed and 7 with registry results posted. The highest registered development stage in this snapshot is Phase 4. These counts measure registry activity; they do not establish that Desmopressin is safe or effective.

Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.

Development history

Trial timeline.

Evidence timeline

20012026

Velocity

Desmopressin studies by start year

Study start year · indexed snapshot

11863020012001: 1 trials2002: 0 trials2003: 0 trials2004: 0 trials2005: 0 trials20062006: 0 trials2007: 0 trials2008: 0 trials2009: 3 trials2010: 1 trials20112011: 1 trials2012: 2 trials2013: 3 trials2014: 2 trials2015: 9 trials20162016: 4 trials2017: 6 trials2018: 3 trials2019: 4 trials2020: 5 trials20212021: 2 trials2022: 11 trials2023: 2 trials2024: 10 trials2025: 4 trials20262026: 2 trials

Development

Trials by phase

Early Phase 11
Phase 14
Phase 210
Phase 312
Phase 418

Current studies

Recruiting or active

Completed studies

Finished records

Stopped studies

Withdrawn or terminated

Showing 6 of 14 studies
Showing 6 of 39 studies
Showing 6 of 7 studies

Full study index

Search Desmopressin trials.

Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.

75 matching studies

Latest publications

Follow the paper trail.

PMID 41221987Davoudi Z, Shahriari S, Rezaei O, Amirdosara M, Vakili K, Zangi M, Samadian M, Haghighimorad M, Ebrahimzade K, Mousavinejad SA, Sayehmiri F, Hallajnejad M, Sharifi G. Incidence and risk factors for transient and permanent central diabetes insipidus following pituitary adenoma surgery: a single center study. Int J Neurosci. 2026 Apr;136(4):417-425. doi: 10.1080/00207454.2025.2564646. Epub 2025 Nov 12.Linked from NCT07712328PMID 39830821Yu Z, Swenson K, Graber E. Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel plus Clascoterone 1% Cream in Adult Patients with Acne. J Clin Aesthet Dermatol. 2025 Jan;18(1):20-23.Linked from NCT07712328PMID 33527610Sugiura A, Weber M, Tabata N, Goto T, Ozturk C, Lin M, Zimmer S, Nickenig G, Sinning JM. QRS duration is a risk indicator of adverse outcomes after MitraClip. Catheter Cardiovasc Interv. 2021 Oct;98(4):E594-E601. doi: 10.1002/ccd.29505. Epub 2021 Feb 1.Linked from NCT07712328PMID 32800304Summers BJ, Wilver NL, Garratt GH, Cougle JR. A Multimethod Analysis of Incompleteness and Visual "Not Just Right" Experiences in Body Dysmorphic Disorder. Behav Ther. 2020 Sep;51(5):764-773. doi: 10.1016/j.beth.2019.11.001. Epub 2019 Nov 26.Linked from NCT07712328PMID 23195688Hayakawa S, Matsumura H, Nakamura N, Yohda M, Ohno H. Spectroscopic characterization of the acid-alkaline transition of a thermophilic cytochrome P450. FEBS Lett. 2013 Jan 4;587(1):94-7. doi: 10.1016/j.febslet.2012.11.017. Epub 2012 Nov 27.Linked from NCT07712328PMID 23959584Takami A. Guest editorial: new basic and clinical aspects of graft-versus-host disease: what can we do without ''Doc'' Brown's help? Int J Hematol. 2013 Sep;98(3):273-4. doi: 10.1007/s12185-013-1417-6. No abstract available.Linked from NCT07712328PMID 33159114Codd LN, Blackmore DG, Vukovic J, Bartlett PF. Exercise reverses learning deficits induced by hippocampal injury by promoting neurogenesis. Sci Rep. 2020 Nov 6;10(1):19269. doi: 10.1038/s41598-020-76176-1.Linked from NCT07712328PMID 35671519Li X, Chen C, Zhang T, Ding N, Zheng P, Yang M. Comparative pharmacokinetic studies of five C-glycosylflavones in normal and urolithiasis model rats following administration of total flavonoids from Desmodium styracifolium by liquid chromatography-tandem mass spectrometry. J Sep Sci. 2022 Aug;45(15):2901-2913. doi: 10.1002/jssc.202200010. Epub 2022 Jun 25.Linked from NCT07712328

Related pages

Keep researching Desmopressin.

Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.